Furthermore, molecular studies demonstrated downregulation of miR-199 in hepatocellular carcinoma (HCC), where it directly suppresses XBP1, providing new insights into HCC pathogenesis (Lou et al., 2018). This evidence concerns the gene XBP1 and hepatocellular carcinoma.